All In Biotech

Free tool

FAERS Monitor: Valchlor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202317 or its brand name (Valchlor, Mechlorethamine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,247

Serious

714

32% of reports

Hospitalization

248

Death reported

155

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pruritus322
  • application site pruritus224
  • application site erythema220
  • application site pain218
  • erythema213
  • condition aggravated194
  • off label use179
  • skin discolouration147
  • rash132
  • skin irritation112
  • blister107
  • death104
  • application site discolouration102
  • application site irritation101
  • disease progression99

Reports by year received

View as table
YearReports
20072
201430
2015256
2016441
2017389
2018253
2019276
2020311
202171
202265
202350
202451
202533
202619

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,912 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
application site discolourationSignal102241.0198.923,540
application site painSignal21893.682.419,692
application site pruritusSignal22493.382.420,188
application site erythemaSignal22079.269.816,794
application site irritationSignal10176.663.37,404
skin discolourationSignal14730.025.74,093
skin irritationSignal11222.919.12,328
blisterSignal10717.914.81,688
erythemaSignal2139.78.51,670
pruritusSignal3227.87.11,951
disease progressionSignal997.86.5587
condition aggravatedSignal1946.05.2810
rashSignal1322.82.4158
off label use1791.91.781
death1041.10.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.